DZ Bank’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

DZ Bank’s Portfolio FPRX Stock Details FPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-30,000	Closed	-$515K	–	1152
2018 Q1	$515K	Buy	+30,000	New	+$585K	﹤0.01%	788

Other funds holding FPRX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DZ Bank's FPRX Position: Q2 2018 in Review

DZ Bank sold out of Five Prime Therapeutics, Inc. (FPRX) in Q2 2018, closing a stake of 30,000 shares — an estimated $515K sold.

DZ Bank first reported a position in FPRX in Q1 2018 and held it in 1 quarter. The position peaked at $515K in Q1 2018. 123 funds tracked by Wall St. Rank hold FPRX as of Q2 2018.

DZ Bank reported no remaining Five Prime Therapeutics, Inc. position as of Q2 2018 after selling out during the quarter.
DZ Bank sold 30,000 Five Prime Therapeutics, Inc. shares in Q2 2018, an estimated $515K.
DZ Bank first reported a position in Five Prime Therapeutics, Inc. in Q1 2018 and held it in 1 quarter.
DZ Bank's Five Prime Therapeutics, Inc. position peaked at $515K in Q1 2018.
123 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q2 2018.

Based on DZ Bank's 13F filing for Q2 2018, filed 14 Aug 2018.